Novavax Inc (NVAX) — Capital Reinvestment Ratio
Novavax Inc (NVAX) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($107.80 Million) in capital expenditures ($2.02 Million). Check Novavax Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Novavax Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Novavax Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see NVAX operating cash flow.
Annual Capital Reinvestment Ratio for Novavax Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Novavax Inc from 2021 to 2021. See NVAX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.18x | $322.95 Million | $57.49 Million | — |